The Saudi Arabia diabetes drugs market is expected to grow at a CAGR of 8.55% during 2024-2032, driven by the increasing prevalence of diabetes, the adoption of innovative medications, and government healthcare initiatives. https://www.imarcgroup.com/saudi-arabia-diabetes-drugs-market